search

Skip to results

Modify your search

Edit your search term, change scope of search Enter search term

Full Text Keywords Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords Title Author/Editor/ORCiD Abstract References/Bibliography

Availability

All content I have access to

Purchased
Free

NARROW

Format

Facet list

Journal Article (1)

Type

Facet list

Abstract (1)

Section

Find a Section

The list will update as you type

Facet list

Clinical Trials: Non-Immunologic (1)

Publication date

Date Range

Published
Updated

Date range

Single date

From Select month

To Select month

Publication date

1-1 of 1

Authors: Erol Wiegert

Save search

Follow your search

Access your saved searches in your account

Name your search

Follow this search

Would you like to receive an alert when new items match your search?

Save search

Sort by

Sort Order Select

Journal Article

CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM)

PDF

Fabio Iwamoto and others

in Neuro-Oncology

Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii83, https://doi.org/10.1093/neuonc/noac209.314

Published: 14 November 2022

Perform this search in

Journals Journals

Books Books

Oxford Academic Oxford Academic

Modify your search

Publication date

CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM) Free

This Feature Is Available To Subscribers Only

CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM)